{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:33:29Z","timestamp":1793306009538,"version":"4.5.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamaneurol.2020.0073","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T11:31:00Z","timestamp":1583148660000},"page":"613","source":"Crossref","is-referenced-by-count":252,"title":["Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome"],"prefix":"10.1001","volume":"77","author":[{"given":"Ian","family":"Miller","sequence":"first","affiliation":[{"name":"Department of Neurology, Nicklaus Children\u2019s Hospital, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E.","family":"Scheffer","sequence":"additional","affiliation":[{"name":"Epilepsy Research Centre, The University of Melbourne at Austin Health and the Royal Children\u2019s Hospital, Melbourne, Victoria, Australia."},{"name":"Florey Institute, Melbourne, Victoria, Australia."},{"name":"Murdoch Children\u2019s Research Institute, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boudewijn","family":"Gunning","sequence":"additional","affiliation":[{"name":"Stichting Epilepsie Instellingen Nederland, Zwolle, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Sanchez-Carpintero","sequence":"additional","affiliation":[{"name":"Pediatric Neurology Unit, Cl\u00ednica Universidad de Navarra, Navarra Institute for Health Research, Instituto de Investigaci\u00f3n Sanitaria de Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gil-Nagel","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Ruber Internacional, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Scott","family":"Perry","sequence":"additional","affiliation":[{"name":"Jane and John Justin Neurosciences Center, Cook Children\u2019s Medical Center, Ft Worth, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell P.","family":"Saneto","sequence":"additional","affiliation":[{"name":"Neuroscience Institute, Division of Pediatric Neurology, Department of Neurology, Seattle Children\u2019s Hospital and University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Checketts","sequence":"additional","affiliation":[{"name":"GW Research, Ltd, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Dunayevich","sequence":"additional","affiliation":[{"name":"Greenwich Biosciences, Inc, Carlsbad, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Knappertz","sequence":"additional","affiliation":[{"name":"Greenwich Biosciences, Inc, Carlsbad, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the GWPCARE2 Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"noi200003r1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype.","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"issue":"4","key":"noi200003r2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology.","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"6","key":"noi200003r3","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1086\/320609","article-title":"De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.","volume":"68","author":"Claes","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"pt 3","key":"noi200003r4","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/brain\/awm002","article-title":"The spectrum of SCN1A-related infantile epileptic encephalopathies.","volume":"130","author":"Harkin","year":"2007","journal-title":"Brain"},{"issue":"3","key":"noi200003r5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/jmg.2008.062323","article-title":"Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients.","volume":"46","author":"Depienne","year":"2009","journal-title":"J Med Genet"},{"issue":"8","key":"noi200003r6","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/brain\/awz195","article-title":"Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort.","volume":"142","author":"Symonds","year":"2019","journal-title":"Brain"},{"key":"noi200003r7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/B978-0-444-52891-9.00065-8","article-title":"Dravet syndrome (severe myoclonic epilepsy in infancy).","volume":"111","author":"Dravet","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"noi200003r8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2017.01.025","article-title":"Optimizing the diagnosis and management of Dravet syndrome: recommendations from a North American consensus panel.","volume":"68","author":"Wirrell","year":"2017","journal-title":"Pediatr Neurol"},{"key":"noi200003r9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1528-1167.2011.03001.x","article-title":"Dravet syndrome: the long-term outcome.","volume":"52","author":"Genton","year":"2011","journal-title":"Epilepsia"},{"issue":"6","key":"noi200003r10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/epi.2010.51.issue-6","article-title":"A long-term follow-up study of Dravet syndrome up to adulthood.","volume":"51","author":"Akiyama","year":"2010","journal-title":"Epilepsia"},{"key":"noi200003r11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eplepsyres.2016.10.006","article-title":"Mortality in Dravet syndrome.","volume":"128","author":"Cooper","year":"2016","journal-title":"Epilepsy Res"},{"issue":"4","key":"noi200003r12","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1933","article-title":"Fatal cerebral edema with status epilepticus in children with Dravet syndrome: report of 5 cases.","volume":"139","author":"Myers","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"noi200003r13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/dmcn.13591","article-title":"Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey.","volume":"60","author":"Lagae","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"noi200003r14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/dmcn.2011.53.issue-s2","article-title":"Current therapeutic procedures in Dravet syndrome.","volume":"53","author":"Chiron","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"noi200003r15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1528-1167.2011.03007.x","article-title":"The pharmacologic treatment of Dravet syndrome.","volume":"52","author":"Chiron","year":"2011","journal-title":"Epilepsia"},{"key":"noi200003r17","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1017\/cjn.2016.249","article-title":"Treatment of Dravet syndrome.","volume":"43","author":"Wirrell","year":"2016","journal-title":"Can J Neurol Sci"},{"issue":"21","key":"noi200003r19","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome.","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"noi200003r20","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome.","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"issue":"10125","key":"noi200003r21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"issue":"20","key":"noi200003r22","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"noi200003r23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale.","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"6","key":"noi200003r24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/epi.2000.41.issue-6","article-title":"Validation of a new quality of life measure for children with epilepsy.","volume":"41","author":"Sabaz","year":"2000","journal-title":"Epilepsia"},{"issue":"4","key":"noi200003r25","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","article-title":"A sharper Bonferroni procedure for multiple tests of significance.","volume":"75","author":"Hochberg","year":"1988","journal-title":"Biometrika"},{"issue":"8","key":"noi200003r26","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/cpdd.v8.8","article-title":"A phase 1, open-label, pharmacokinetic trial to investigate possible drug-drug interactions between clobazam, stiripentol, or valproate and cannabidiol in healthy subjects.","volume":"8","author":"Morrison","year":"2019","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"8","key":"noi200003r27","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy.","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia"},{"issue":"2","key":"noi200003r32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1528-1167.2010.02915.x","article-title":"Factors determining response to antiepileptic drugs in randomized controlled trials: a systematic review and meta-analysis.","volume":"52","author":"Rheims","year":"2011","journal-title":"Epilepsia"},{"key":"noi200003r16","year":"2018"},{"key":"noi200003r18","year":"2018"},{"key":"noi200003r28","author":"Devinsky"},{"key":"noi200003r29","author":"Thiele"},{"key":"noi200003r30","author":"Szaflarski"},{"key":"noi200003r31","author":"Tayo","year":"2018"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2762458\/jamaneurology_miller_2020_oi_200003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T08:40:09Z","timestamp":1722501609000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2762458"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2020.0073","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}